Beyond Air, Inc. Common Stock (XAIR)

Price$0.49

Value ScoreB

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-78.53%

Price vs S&P 500 (4W)-15.48%

VGM Score54.11

Market Capitalization$5.98M

All Metrics

Book Value / Share (Quarterly)$0.97

P/TBV (Annual)1.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)62.09%

Cash Flow / Share (Quarterly)$-2.63

Price vs S&P 500 (YTD)-47.57%

Gross Margin (TTM)1.82%

Net Profit Margin (TTM)-447.73%

EPS (TTM)$-5.43

10-Day Avg Trading Volume0.25M

EPS Excl Extra (TTM)$-5.43

Revenue Growth (5Y)-13.66%

EPS (Annual)$-13.77

ROI (Annual)-199.35%

Gross Margin (Annual)-44.89%

Net Profit Margin (5Y Avg)-2120.89%

Cash / Share (Quarterly)$1.39

Revenue Growth QoQ (YoY)104.66%

ROA (Last FY)-155.10%

Revenue Growth TTM (YoY)129.04%

EBITD / Share (TTM)$-4.23

ROE (5Y Avg)-173.09%

Operating Margin (TTM)-418.27%

Cash Flow / Share (Annual)$-10.68

P/B Ratio0.74x

P/B Ratio (Quarterly)0.69x

Net Income / Employee (Annual)$-764,300

EV / Revenue (TTM)3.08x

Net Interest Coverage (TTM)-47.33x

ROA (TTM)-98.48%

EPS Incl Extra (Annual)$-13.77

Current Ratio (Annual)3.20x

Quick Ratio (Quarterly)3.83x

3-Month Avg Trading Volume0.33M

52-Week Price Return-87.89%

Revenue / Employee (TTM)$113,500

Tangible BV / Share (Quarterly)$0.84

P/S Ratio (Annual)1.61x

Asset Turnover (Annual)0.12x

52-Week High$5.84

Operating Margin (5Y Avg)-2130.70%

EPS Excl Extra (Annual)$-13.77

CapEx CAGR (5Y)171.34%

Tangible BV CAGR (5Y)-6.91%

26-Week Price Return-62.60%

Quick Ratio (Annual)1.60x

13-Week Price Return-52.75%

Total Debt / Equity (Annual)0.72x

Current Ratio (Quarterly)5.12x

Enterprise Value$21.31M

Revenue / Share Growth (5Y)3.80%

Asset Turnover (TTM)0.22x

Book Value / Share Growth (5Y)23.91%

Revenue / Employee (Annual)$60,700

Inventory Turnover (Annual)2.36x

Pretax Margin (Annual)-1308.48%

Cash / Share (Annual)$1.68

3-Month Return Std Dev102.75%

Net Income / Employee (TTM)$-508,200

ROE (Last FY)-343.26%

Net Interest Coverage (Annual)-13.69x

EPS Basic Excl Extra (Annual)$-13.77

Receivables Turnover (TTM)7.74x

Total Debt / Equity (Quarterly)2.71x

EPS Incl Extra (TTM)$-5.43

ROI (TTM)-129.07%

P/S Ratio (TTM)0.86x

Pretax Margin (5Y Avg)-2203.14%

Revenue / Share (Annual)$1.09

Tangible BV / Share (Annual)$2.99

Price vs S&P 500 (52W)-116.10%

Year-to-Date Return-36.64%

5-Day Price Return14.71%

EPS Normalized (Annual)$-13.77

ROA (5Y Avg)-88.40%

Net Profit Margin (Annual)-1258.43%

Month-to-Date Return-12.41%

Cash Flow / Share (TTM)$-2.15

EBITD / Share (Annual)$-12.99

Operating Margin (Annual)-1268.12%

LT Debt / Equity (Annual)0.68x

ROI (5Y Avg)-122.91%

LT Debt / Equity (Quarterly)2.71x

EPS Basic Excl Extra (TTM)$-5.43

P/TBV (Quarterly)0.79x

P/B Ratio (Annual)1.66x

Inventory Turnover (TTM)3.28x

Pretax Margin (TTM)-462.58%

Book Value / Share (Annual)$3.29

Price vs S&P 500 (13W)-62.50%

Beta0.26x

P/FCF (Annual)4.67x

Revenue / Share (TTM)$0.80

ROE (TTM)-279.58%

52-Week Low$0.38

vGradeB

gGradeB

mGradeD

vgmGradeC

Show chart for

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
XAIRBeyond Air, Inc. Common Stock	B	B	D	$0.49
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a proprietary nitric oxide (NO) generator and delivery system, extracting NO from ambient air for inhaled therapeutic treatment. The company is advancing its technology for pulmonary hypertension and lower respiratory tract infections.